Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT06798064
NCT06798064No Longer AvailableNot Applicable

Expanded Access Using Allogeneic Bone-marrow Derived Human Mesenchymal Stem Cells (Allo-hMSC) for a Individual Parkinson's Disease Subject

Mya Schiess1 site in 1 countryStarted: January 29, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
No Longer Available
Sponsor
Locations
1
Study OverviewEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This is a expanded access use of allogeneic bone marrow-derived mesenchymal stem cells for a single subject with moderate Parkinson's disease that has progressed.

Study Design

Study Type
Expanded Access

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Mya Schiess
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Mya Schiess

Professor

The University of Texas Health Science Center, Houston

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 1
Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's DiseaseCrohn's DiseaseFistula
NCT01144962Leiden University Medical Center21
No Longer Available
Not Applicable
Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)Acute Ischemic StrokeMesenchymal Stem CellsStroke, AcuteStroke/Brain AttackStroke, Ischemic
NCT05522569University of Miami
Withdrawn
Phase 1
Stem Cells for the Treatment of PouchitisUlcerative Colitis ChronicInflammatory Bowel DiseasesPouch, IlealCrohn's DiseasePouchitis
NCT05578508The Cleveland Clinic
Completed
Not Applicable
Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients with Refractory Perianal Crohn*s DiseasefistulaM. Crohn10017969
NL-OMON36386eids Universitair Medisch Centrum21
Active, not recruiting
Not Applicable
Allogeneic Bone Marrow Derived Mesenchymal Stem Cellsfor the Treatment of Fistulas in Patients withRefractory Perianal Crohn’s Disease - allo bmMSCs CD fistula
EUCTR2009-015680-14-NLeiden University Medical Center